학술논문
Ocrelizumab exposure in relapsing–remitting multiple sclerosis: 10-year analysis of the phase 2 randomized clinical trial and its extension
Document Type
Article
Author
Source
In: Journal of Neurology . (Journal of Neurology, February 2024, 271(2):642-657)
Subject
Language
English
ISSN
14321459
03405354
03405354